PI Nasdaq Electronic Components, Nec Financials FY2016βFY2025
Impinj Inc had $361M of revenue in fiscal 2025, down 1.4% on the year before. Over five years, revenue changed +21.1% a year on average.
Last close Β· Oct 23, 2026
$167.07
2.7%Hi! I read Impinj Incβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β1.4%
No. Sales fell 1.4% last year.
Does it make a profit?
β3.0%
No. It lost money last year.
Does profit turn into cash?
12.7%
Yes. 12.7% of sales ends up as free cash.
Is debt under control?
7.4x
Heavy. Repaying its debt would take 7.4 years of operating profit.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Impinj Inc did it, and the next one. Share prices often move a lot on those days.
Next results
October 28, 2026
Wednesday Β· in 3 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Jul 29, 2026 | Q2 '26 | After the market closes | 8-K β |
| Apr 29, 2026 | Q1 '26 | After the market closes | 8-K β |
| Jan 13, 2026 | Q4 '25 | After the market closes | 8-K β |
| Oct 29, 2025 | Q3 '25 | After the market closes | 8-K β |
| Jul 30, 2025 | Q2 '25 | After the market closes | 8-K β |
| Apr 23, 2025 | Q1 '25 | After the market closes | 8-K β |
| Jan 14, 2025 | Q4 '24 | After the market closes | 8-K β |
| Oct 23, 2024 | Q3 '24 | After the market closes | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Impinj Inc had $361M of revenue in fiscal 2025, down 1.4% on the year before. Over five years, revenue changed +21.1% a year on average. Its operating margin was β0.2%, up 1.7Β pts: of every 100 in sales, about β0 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
KIRA Β· Impinj Inc lost $10.8M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $45.9M in fiscal 2025, 12.7% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Impinj Inc owes $106M more than it holds in cash, about 7.4 years of operating profit.
Cash, debt and the ratios that show how comfortably Impinj Inc can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $193M | $174M | $113M | $165M | $175M |
| Debt incl. finance leases | $288M | $280M | $282M | $283M | $281M |
| Net debt / EBITDA | β | β | β | 18.2x | 7.4x |
| Debt / equity | β | 18.0x | 8.3x | 1.9x | 1.3x |
| Interest coverage | β14.6x | β4.0x | β9.0x | β1.5x | β0.2x |
| Current ratio | 7.2x | 6.5x | 8.7x | 1.0x | 2.7x |
| Quick ratio | 6.6x | 5.4x | 5.6x | 0.7x | 2.0x |
| Total assets | $316M | $350M | $359M | $489M | $545M |
| Total liabilities | $327M | $334M | $325M | $339M | $336M |
| Shareholders' equity | β$11.1M | $15.6M | $34.1M | $150M | $209M |
| Net debt (β = net cash) | $94.9M | $106M | $169M | $119M | $106M |
KIRA Β· Its return on capital was β0.2%: every 100 invested in the business earned about β0 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
KIRA Β· Impinj Inc passes 6 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 2 / 9 | 5 / 9 | 1 / 9 | 5 / 9 | 6 / 9 | 3 / 9 | 6 / 9 | 6 / 9 |
| Accruals ratio | 4.7% | 11.6% | β15.8% | β15.4% | β16.6% | β22.1% | β7.5% | 1.7% | β20.6% | β13.5% |
| Altman Z'' | 4.16 | 3.38 | β0.38 | 1.60 | β0.76 | 0.01 | 0.44 | β0.25 | β2.29 | 0.81 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $112M | $125M | $123M | $153M | $139M | $190M | $258M | $308M | $366M | $361M |
| Gross profit | $59.5M | $64.9M | $58.3M | $74.0M | $65.1M | $99.0M | $138M | $152M | $189M | $190M |
| Research and development | $25.2M | $32.2M | $34.2M | $38.9M | $48.6M | $64.1M | $74.1M | $88.6M | $98.8M | $103M |
| Operating income | β$0.5M | β$17.0M | β$34.9M | β$21.7M | β$47.1M | β$37.2M | β$19.5M | β$43.5M | β$7.1M | β$0.7M |
| Interest expense | $1.6M | $0.9M | $1.4M | $1.8M | $5.4M | $2.6M | $4.9M | $4.8M | $4.9M | $4.4M |
| Pretax income | β$1.5M | β$17.4M | β$35.5M | β$22.8M | β$51.8M | β$51.1M | β$24.1M | β$43.7M | $41.0M | β$10.9M |
| Income tax | $0.2M | β$0.1M | β$0.2M | $0.2M | $0.1M | $0.2M | $0.2M | β$0.3M | $0.2M | β$0.1M |
| Net income | β$1.7M | β$17.3M | β$35.2M | β$23.0M | β$51.9M | β$51.3M | β$24.3M | β$43.4M | $40.8M | β$10.8M |
| Net income to common | β$7.9M | β$17.3M | β$35.2M | β | β | β | β$24.3M | β$43.4M | $40.8M | β |
| Diluted EPS | β$0.74 | β$0.84 | β$1.65 | β$1.05 | β$2.28 | β$2.12 | β$0.95 | β$1.62 | $1.39 | β$0.37 |
| Diluted shares | 0.01B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | β$9.5M | β$35.9M | β$11.8M | $4.7M | β$16.9M | $6.5M | $0.6M | β$49.4M | $128M | $58.7M |
| Capital expenditure | $3.5M | $6.6M | $6.4M | $2.4M | $3.1M | $16.2M | $12.1M | $18.6M | $17.1M | $12.9M |
| Free cash flow | β$13.0M | β$42.4M | β$18.1M | $2.3M | β$20.0M | β$9.8M | β$11.4M | β$68.0M | $111M | $45.9M |
| Depreciation and amortization | $2.9M | $4.0M | $4.5M | $4.8M | $4.5M | $4.6M | $6.0M | $13.6M | $13.6M | $15.0M |
| Stock-based compensation | $2.8M | $7.4M | $11.3M | $18.5M | $25.7M | $40.5M | $42.4M | $48.0M | $56.5M | $55.3M |
| Acquisitions | β | β | β | β | β | β | β | $23.4M | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $101M | $58.1M | $56.1M | $116M | $106M | $193M | $174M | $113M | $165M | $175M |
| Total debt | $12.3M | $9.6M | $23.7M | $50.9M | $54.6M | $288M | $280M | $282M | $283M | $281M |
| Finance lease liabilities | β | β | β | $0.3M | β | β | β | β | β | β |
| Current assets | $149M | $130M | $121M | $177M | $171M | $256M | $275M | $270M | $326M | $339M |
| Current liabilities | $25.4M | $19.9M | $23.0M | $19.5M | $27.6M | $35.5M | $42.4M | $30.9M | $331M | $127M |
| Inventory | $27.7M | $47.1M | $44.7M | $34.2M | $36.3M | $22.0M | $46.4M | $97.2M | $99.3M | $85.0M |
| Property and equipment, net | $14.9M | $18.1M | $19.8M | $17.4M | $16.5M | $27.5M | $39.0M | $44.9M | $50.6M | $50.3M |
| Goodwill | $3.9M | β | β | β | β | $3.9M | $3.9M | $19.7M | $18.7M | $20.7M |
| Intangible assets | β | β | β | β | β | β | β | $13.9M | $10.3M | $9.5M |
| Total assets | $168M | $152M | $145M | $215M | $208M | $316M | $350M | $359M | $489M | $545M |
| Total liabilities | $43.5M | $33.1M | $47.2M | $89.8M | $98.5M | $327M | $334M | $325M | $339M | $336M |
| Shareholders' equity | $124M | $119M | $97.9M | $125M | $109M | β$11.1M | $15.6M | $34.1M | $150M | $209M |
| Margins | ||||||||||
| Gross margin | 52.9% | 51.8% | 47.5% | 48.4% | 46.9% | 52.0% | 53.5% | 49.4% | 51.6% | 52.5% |
| Operating margin | β0.4% | β13.6% | β28.4% | β14.2% | β33.9% | β19.6% | β7.6% | β14.1% | β1.9% | β0.2% |
| EBITDA margin | 2.1% | β10.4% | β24.7% | β11.0% | β30.6% | β17.2% | β5.2% | β9.7% | 1.8% | 4.0% |
| Net margin | β1.5% | β13.8% | β28.7% | β15.0% | β37.4% | β26.9% | β9.4% | β14.1% | 11.2% | β3.0% |
| FCF margin | β11.6% | β33.9% | β14.8% | 1.5% | β14.4% | β5.1% | β4.4% | β22.1% | 30.4% | 12.7% |
| Returns | ||||||||||
| Return on capital | β1.1% | β19.1% | β42.1% | β28.7% | β64.6% | β35.1% | β12.6% | β16.9% | β2.6% | β0.2% |
| Return on capital employed | β0.3% | β12.9% | β28.6% | β11.1% | β26.1% | β13.3% | β6.3% | β13.2% | β4.5% | β0.2% |
| Return on equity | β1.3% | β14.3% | β32.5% | β20.6% | β44.3% | β104.6% | β1,076.5% | β174.4% | 44.4% | β6.0% |
| Return on assets | β1.0% | β10.8% | β23.7% | β12.8% | β24.6% | β19.6% | β7.3% | β12.2% | 9.6% | β2.1% |
| Return on tangible equity | β6.6% | β14.6% | β36.0% | β18.4% | β47.6% | β | β207.5% | β8,307.7% | 33.8% | β6.1% |
| Growth | ||||||||||
| Revenue growth | β | 11.6% | β2.1% | 24.6% | β9.1% | 37.0% | 35.5% | 19.3% | 19.0% | β1.4% |
| Net income growth | β | β | β | β | β | β | β | β | β | β126.6% |
| EPS growth | β | β | β | β | β | β | β | β | β | β126.6% |
| FCF growth | β | β | β | β | β975.4% | β | β | β | β | β58.7% |
| Share count change | β | 91.9% | 3.2% | 2.4% | 4.4% | 5.9% | 5.6% | 4.7% | 10.2% | β0.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | β37.1x | β | β | β | β | β | β | β | 18.2x | 7.4x |
| Debt / equity | 0.1x | 0.1x | 0.2x | 0.4x | 0.5x | β | 18.0x | 8.3x | 1.9x | 1.3x |
| Interest coverage | β0.3x | β18.7x | β24.9x | β12.1x | β8.7x | β14.6x | β4.0x | β9.0x | β1.5x | β0.2x |
| Current ratio | 5.9x | 6.5x | 5.3x | 9.1x | 6.2x | 7.2x | 6.5x | 8.7x | 1.0x | 2.7x |
| Quick ratio | 4.8x | 4.2x | 3.3x | 7.3x | 4.9x | 6.6x | 5.4x | 5.6x | 0.7x | 2.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.1% | 5.2% | 5.2% | 1.6% | 2.2% | 8.5% | 4.7% | 6.0% | 4.7% | 3.6% |
| Stock comp / revenue | 2.5% | 5.9% | 9.2% | 12.1% | 18.5% | 21.3% | 16.5% | 15.6% | 15.4% | 15.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 2.0 | 5.0 | 1.0 | 5.0 | 6.0 | 3.0 | 6.0 | 6.0 |
| Altman Z'' | 4.2 | 3.4 | β0.4 | 1.6 | β0.8 | 0.0 | 0.4 | β0.2 | β2.3 | 0.8 |
| Accruals ratio | 4.7% | 11.6% | β15.8% | β15.4% | β16.6% | β22.1% | β7.5% | 1.7% | β20.6% | β13.5% |
Source: SEC EDGAR XBRL filings (CIK 0001114995). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
